Richard Wust
Tuebingen, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Methodological validation of Miro1 retention as a candidate Parkinson's disease biomarker.
Journal: NPJ Parkinson's disease
Published: April 08, 2025
A co-culture model of dopaminergic and glutamatergic neurons derived from patients with idiopathic schizophrenia reveals a hypodopaminergic phenotype.
Journal: Molecular psychiatry
Published: August 14, 2024
Patient iPSC-derived neural progenitor cells display aberrant cell cycle control, p53, and DNA damage response protein expression in schizophrenia.
Journal: BMC psychiatry
Published: July 05, 2024
Microglia-neuron interactions in schizophrenia.
Journal: Frontiers in cellular neuroscience
Published: November 27, 2023
Regulation of synaptic connectivity in schizophrenia spectrum by mutual neuron-microglia interaction.
Journal: Communications biology
Published: June 24, 2022
Generation and characterization of human induced pluripotent stem cells lines from four patients diagnosed with schizophrenia and one healthy control.
Journal: Stem cell research
Published: July 31, 2020
The potential of induced pluripotent stem cells for discriminating neurodevelopmental disorders.
Journal: Stem cells translational medicine
Published: May 13, 2020
Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson's disease.
Journal: Brain : a journal of neurology
Published: April 18, 2017
Mutation analyses and association studies to assess the role of the presenilin-associated rhomboid-like gene in Parkinson's disease.
Journal: Neurobiology of aging
Published: December 02, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026